OUR PIPELINE
With our partners in Biotech and Pharma we have built a track record of 32+ successful drug discovery and development partnerships at multiple stages of maturity, clinical development and market readiness. Together with our partners we drive therapeutics programs through all relevant inflection points independent of disease area and therapeutic modality.| Therapeutic Area | Indication | Target | Stage | Partner |
|---|---|---|---|---|
| Oncology | Solid tumors | AKAP-4 | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Verik bio |
| Oncology | Pancreatic cancer | PI3K | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Land of Hessen |
| Oncology | Multiple oncology indications | MetAP2 | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Cureteq |
| Oncology | Multiple oncology indications | OX40 | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Cureteq |
| Oncology | Pancreatic cancer | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Confidential |
| Oncology and Inflammatory diseases | Confidential | PIM family | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Inflection Biosciences |
| Immunology | Multiple immunology indications | IL-17 | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Cureteq |
| Inflammatory disorders | Confidential | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Chain Pharmaceuticals |
| Inflammatory disorders | Confidential | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Chain Pharmaceuticals |
| Inflammatory disorders | Confidential | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Chain Pharmaceuticals |
| Neurodegenerative diseases | Alzhiemers disease | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Discoveric bio alpha |
| Mental health disorders | Depression | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Confidential |
| Mental health disorders | Anxiety | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Confidential |
| Mental health disorders | Sleep disorder | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Confidential |
| Mental health disorders | ADHD | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Confidential |
| Mental health disorders | Opoid abuse | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Confidential |
| Mental health disorders | Schizophrenia | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Confidential |
| Sensori-neural diseases | Confidential | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Confidential |
| Metabolic diseases | T1D and co-morbidities | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Confidential |
| Cardiology | Confidential | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Confidential |
| Dermatology + others | Confidential | TLR | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Confidential |
| Dermatology | Confidential | TLR | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Chain Pharmaceuticals |
| Dermatology | Confidential | TLR | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Chain Pharmaceuticals |
| Infectious diseases | Antimicrobial resistance | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Discoveric bio beta |
| Infectious diseases | Covid-19 | 3CLPro | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Land of Hessen |
| Pain related indications | Confidential | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Chain Pharmaceuticals |
| ICU treatment | Confidential | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Chain Pharmaceuticals |
| Rare diseases | Confidential | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Confidential |
| Rare diseases | Confidential | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Confidential |
| Multiple TAs | Confidential | Confidential | Pre – DiscoveryDiscoveryPre-ClinicalClinicalLaunchPost-Launch | Confidential |
Innoplexus wins Horizon Interactive Gold Award for Curia App
Read More